Status:
NOT_YET_RECRUITING
Targeting the Skeletal Muscle to Treat Metabolic Dysfunction-associated Steatotic Liver Disease
Lead Sponsor:
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Collaborating Sponsors:
Concerted Research Action
Fonds National de la Recherche Scientifique
Conditions:
Metabolic Dysfunction-associated Steatotic Liver Disease
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Muscle changes including myosteatosis are reported as highly prevalent in metabolic dysfunction-associated steatotic liver disease (MASLD). Recent studies highlighted a link between muscle fat content...
Detailed Description
In this monocenter interventional study, we will assess the impact of physical activity on muscle fat content and liver disease severity in MASLD as well as the mechanisms mediating the potential bene...
Eligibility Criteria
Inclusion
- confirmed MASLD at abdominal imaging
- confirmed excessive muscle lipid content at imaging
- stable weight
Exclusion
- severe comorbidities including active malignancies, neuromuscular degenerative diseases
- contraindications to physical activity
- excessive alcohol consumption
Key Trial Info
Start Date :
October 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2026
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06506513
Start Date
October 1 2024
End Date
September 1 2026
Last Update
July 17 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Cliniques universitaires Saint-Luc
Brussels, Belgium, 1200
2
Centre d'investigation clinique en nutrition
Louvain-la-Neuve, Belgium, 1348